Article info

Extended report
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

Authors

  1. Correspondence to Professor Thomas Bardin, Rhumatologie, Hôpital Lariboisière, Assistance Publique Hôpitaux de Paris, 2, rue A Paré, 75010 Paris; thomas.bardin{at}aphp.fr
View Full Text

Citation

Bardin T, Keenan RT, Khanna PP, et al
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

Publication history

  • Received January 17, 2016
  • Revised August 25, 2016
  • Accepted October 5, 2016
  • First published November 7, 2016.
Online issue publication 
April 06, 2017

Article Versions

  • Lay summary

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.